Incorrect username and/or password, please try again or click to reset.

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!

Tredaptive modified-release tablets - withdrawn throughout the European Union

2014-12-17 14:58:37 (11 year(s) ago)

Summary

(Merck Sharp & Dohme Ltd) Study showed failure to reduce major vascular events and increase in non-fatal serious adverse events – class 2 action within 48 hours. (EL (13)A/02)

Read full MHRA article

Respond to this alert